* iSpecimen Inc ISPC.OQ reported a quarterly adjusted loss
of 19
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -39
cents. The lone analyst forecast for the quarter was for a loss
of 28 cents per share.
* Revenue rose 76.2% to $2.86 million from a year ago;
analysts
expected $2.88 million.
* iSpecimen Inc's reported EPS for the quarter was a loss
of 19
cents.
* The company reported a quarterly loss of $2.11 million.
* iSpecimen Inc shares had fallen by 22.8% this quarter and
lost 52.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "buy"
Wall Street's median 12-month price target for iSpecimen Inc is
$3.00
This summary was machine generated from LSEG data August 6 at
01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 -0.28 -0.19 Beat
Mar. 31 2024 -0.27 -0.32 Missed
Dec. 31 2023 -0.24 -0.32 Missed
Sep. 30 2023 -0.35 -0.23 Beat